Gene · 5745
Papers2,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Timing of osteoporosis therapies following fracture: the current status. | Ther Adv Endocrinol Metab | 2022 | 35899183 | PubTator, text mining | PubMed |
| A NanoBRET-Based H3R Conformational Biosensor to Study Real-Time H3 Receptor Pharmacology in Cell Membranes and Living Cells. | Int J Mol Sci | 2022 | 35897787 | PubTator, text mining | PubMed |
| Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors. | Int J Mol Sci | 2022 | 35897648 | PubTator, text mining | PubMed |
| A roadmap to parathyroidectomy for kidney transplant candidates. | Clin Kidney J | 2022 | 35892022 | PubTator, text mining | PubMed |
| Autosomal Dominant Hypocalcemia Type 1: A Systematic Review. | J Bone Miner Res | 2022 | 35879818 | PubTator, text mining | PubMed |
| The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection. | Front Cell Infect Microbiol | 2022 | 35873161 | PubTator, text mining | PubMed |
| The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture. | Front Endocrinol (Lausanne) | 2022 | 35872985 | PubTator, text mining | PubMed |
| Effect of cell receptors in the pathogenesis of osteoarthritis: Current insights. | Open Life Sci | 2022 | 35859614 | PubTator, text mining | PubMed |
| PTHrP promotes subchondral bone formation in TMJ-OA. | Int J Oral Sci | 2022 | 35853862 | PubTator, text mining | PubMed |
| Bone remodeling: an operational process ensuring survival and bone mechanical competence. | Bone Res | 2022 | 35851054 | PubTator, text mining | PubMed |
| Membranes under the Magnetic Lens: A Dive into the Diverse World of Membrane Protein Structures Using Cryo-EM. | Chem Rev | 2022 | 35849490 | PubTator, text mining | PubMed |
| Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis. | Front Cell Dev Biol | 2022 | 35846376 | PubTator, text mining | PubMed |
| Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance. | Front Endocrinol (Lausanne) | 2022 | 35846276 | PubTator, text mining | PubMed |
| The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review. | Biomater Transl | 2022 | 35837343 | PubTator, text mining | PubMed |
| MiR-181b Inhibits the Proliferation of Lymphoma Rajixi Cell Line by Regulating the Expression of Target Gene FAMLF. | Cell Mol Biol (Noisy-le-grand) | 2022 | 35818220 | PubTator, text mining | PubMed |
| Editorial: Calcium: An Overview From Physiology to Pathological Mineralization. | Front Endocrinol (Lausanne) | 2022 | 35813661 | PubTator, text mining | PubMed |
| Targeted Long-Read Sequencing Identifies a Retrotransposon Insertion as a Cause of Altered GNAS Exon A/B Methylation in a Family With Autosomal Dominant Pseudohypoparathyroidism Type 1b (PHP1B). | J Bone Miner Res | 2022 | 35811283 | PubTator, text mining | PubMed |
| Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis. | Prenat Diagn | 2022 | 35808914 | PubTator, text mining | PubMed |
| Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis. | Front Pharmacol | 2022 | 35774616 | PubTator, text mining | PubMed |
| Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival. | BMC Cancer | 2022 | 35761298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5745/papers?page=27